Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Potential US election impact on the FDA?

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Nov 07, 2024 5:15pm

147 Views

Post# 36301994

RE:RE:RE:Potential US election impact on the FDA?

The time it takes for the US government to change it will be well into the new year. By that time TLT should have BTD and possibly AA , for NMIBC . After that happens and the news gets out about a potential cure for many different cancers with little to no side effects, I'm sure RKJ will be very happy to approve a vaccine to cure many types of blood cancers.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant